0.43
price down icon4.44%   -0.02
after-market After Hours: .43
loading
cbdMD Inc stock is traded at $0.43, with a volume of 397.35K. It is down -4.44% in the last 24 hours and down -27.12% over the past month.
See More
Previous Close:
$0.45
Open:
$0.4505
24h Volume:
397.35K
Relative Volume:
0.22
Market Cap:
$2.69M
Revenue:
$23.45M
Net Income/Loss:
$-19.98M
P/E Ratio:
-0.034
EPS:
-12.63
Net Cash Flow:
$-2.65M
1W Performance:
-11.16%
1M Performance:
-27.12%
6M Performance:
-19.32%
1Y Performance:
-39.27%
1-Day Range:
Value
$0.422
$0.4505
1-Week Range:
Value
$0.4214
$0.4951
52-Week Range:
Value
$0.3111
$1.34

cbdMD Inc Stock (YCBD) Company Profile

Name
Name
cbdMD Inc
Name
Phone
704-445-5800
Name
Address
4521 Sharon Road, Charlotte, NC
Name
Employee
50
Name
Twitter
@cbdmd_usa
Name
Next Earnings Date
2024-08-14
Name
Latest SEC Filings
Name
YCBD's Discussions on Twitter

Compare YCBD with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
YCBD
cbdMD Inc
0.43 2.69M 23.45M -19.98M -2.65M -12.63
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
165.31 74.02B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.15 45.90B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.08 44.64B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.78 19.23B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
128.57 13.67B 612.78M -86.37M -62.91M -0.87

cbdMD Inc Stock (YCBD) Latest News

pulisher
Feb 22, 2025

cbdMD (NYSEAMERICAN:YCBD) Stock Price Up 1.5% – Time to Buy? - Defense World

Feb 22, 2025
pulisher
Feb 19, 2025

cbdMD announces additional conversions of its convertible notes - MSN

Feb 19, 2025
pulisher
Feb 15, 2025

cbdMD, Inc. (AMEX:YCBD) Q1 2025 Earnings Call Transcript - Insider Monkey

Feb 15, 2025
pulisher
Feb 14, 2025

cbdMD Achieves Profitability, Highlights Growth in Earnings Call - TipRanks

Feb 14, 2025
pulisher
Feb 14, 2025

cbdMD targets growth with new product launches and improved profitability in Q1 2025 - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

cbdMD Inc (YCBD) Q1 2025 Earnings Call Highlights: Achieving Profitability and Debt-Free Status By GuruFocus - Investing.com Canada

Feb 14, 2025
pulisher
Feb 13, 2025

cbdMD, Inc. Reports Improved Earnings Amid Industry Challenges - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

cbdMD posts first-quarter profit despite lower sales - Green Market Report

Feb 13, 2025
pulisher
Feb 13, 2025

cbdMD Generates $5.1 Million in Revenue, Positive Earnings - Yahoo Finance

Feb 13, 2025
pulisher
Feb 07, 2025

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results - The Kingston Whig-Standard

Feb 07, 2025
pulisher
Feb 07, 2025

cbdMD Earnings: Strategic Financial Review & Market Position Update Coming Feb 13 - StockTitan

Feb 07, 2025
pulisher
Feb 06, 2025

cbdMD Inc [YCBD] is 54.03% higher this YTD. Is it still time to buy? - The DBT News

Feb 06, 2025
pulisher
Feb 06, 2025

A Look at cbdMD Inc (YCBD) Shares in the Recent Past Indicates Growth - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

cbdMD Inc (YCBD)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

YCBD’s Stock Market Adventure: 62.61% YTD Growth Amidst Volatility - The InvestChronicle

Feb 04, 2025
pulisher
Jan 30, 2025

Taking on analysts’ expectations and winning: cbdMD Inc (YCBD) - SETE News

Jan 30, 2025
pulisher
Jan 28, 2025

CBD Hemp Oil Consumption Market Predicted at 17.97%CAGR to Cross 24.08 Billion USD by 2032 | Riot CBD, - EIN News

Jan 28, 2025
pulisher
Jan 15, 2025

cbdMD Announces It Has Fully Satisfied Its Notes - The Kingston Whig-Standard

Jan 15, 2025
pulisher
Jan 15, 2025

cbdMD Eliminates All Debt Through Early Note Conversion, Strengthens Financial Position - StockTitan

Jan 15, 2025
pulisher
Jan 08, 2025

cbdMD Announces Additional Conversions of Its Convertible Notes - The Kingston Whig-Standard

Jan 08, 2025
pulisher
Jan 04, 2025

cbdMD discloses NYSE listing compliance notice - MSN

Jan 04, 2025
pulisher
Jan 03, 2025

cbdMD receives NYSE non-compliance notice - MSN

Jan 03, 2025
pulisher
Jan 03, 2025

cbdMD Faces NYSE American Delisting Risk Over $2M Equity Requirement Shortfall - StockTitan

Jan 03, 2025
pulisher
Jan 03, 2025

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard - Newsfile

Jan 03, 2025
pulisher
Dec 27, 2024

cbdMD (AMEX:YCBD) Stock Quotes, Forecast and News Summary - Benzinga

Dec 27, 2024
pulisher
Dec 24, 2024

cbdMD Expands Board with CEO T. Ronan Kennedy - MSN

Dec 24, 2024
pulisher
Dec 23, 2024

cbdMD Strengthens Leadership: CEO Kennedy Joins Board After Successful Business Turnaround - StockTitan

Dec 23, 2024
pulisher
Dec 18, 2024

cbdMD posts lower annual sales, mixed fourth quarter - Green Market Report

Dec 18, 2024
pulisher
Dec 18, 2024

cbdMD Inc. (YCBD) reports earnings - Quartz

Dec 18, 2024
pulisher
Dec 18, 2024

cbdMD Slashes Losses by $19.1M Despite Sales Dip; Launches New Product Lines - StockTitan

Dec 18, 2024
pulisher
Dec 18, 2024

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results - The Kingston Whig-Standard

Dec 18, 2024
pulisher
Dec 18, 2024

Dream Industrial REIT (DIR-UN-T) QuotePress Release - The Globe and Mail

Dec 18, 2024
pulisher
Dec 18, 2024

cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement - Newsfile

Dec 18, 2024
pulisher
Dec 17, 2024

cbdMD, Inc. Reschedules Earnings Release and Conference Call - Newsfile

Dec 17, 2024
pulisher
Dec 12, 2024

S&P 500 Information Technology [Sector] (SRIT) QuotePress Release - The Globe and Mail

Dec 12, 2024
pulisher
Dec 12, 2024

cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results - The Kingston Whig-Standard

Dec 12, 2024
pulisher
Dec 10, 2024

YCBD Stock Touches 52-Week Low at $0.41 Amid Market Challenges - Investing.com

Dec 10, 2024
pulisher
Nov 27, 2024

cbdMD Extends Lease on Executive Office and Warehouse By Investing.com - Investing.com Canada

Nov 27, 2024
pulisher
Nov 27, 2024

cbdMD Extends Lease on Executive Office and Warehouse - Investing.com

Nov 27, 2024
pulisher
Nov 20, 2024

CbdMD : Learn whether hemp cultivation and CBD production is truly sustainable by examining factors like water usage, soil health, and carbon footprint. - Marketscreener.com

Nov 20, 2024
pulisher
Nov 14, 2024

CbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers - Barchart

Nov 14, 2024
pulisher
Nov 14, 2024

cbdMD Launches THC Seltzers in $4B Market Push with Fast-Acting Technology | YCBD Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers - Newsfile

Nov 14, 2024
pulisher
Nov 13, 2024

CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine - Quantisnow

Nov 13, 2024
pulisher
Nov 08, 2024

YCBD stock touches 52-week low at $0.43 amid market challenges - Investing.com

Nov 08, 2024
pulisher
Oct 31, 2024

cbdMD Launches Line of CBD Products with Wegmans Food Markets - Newsfile

Oct 31, 2024
pulisher
Oct 22, 2024

CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for 3000MG Pain Relief Cream, Setting the Stage for Unprecedented Growth - Quantisnow

Oct 22, 2024
pulisher
Oct 18, 2024

cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 2.5% – What’s Next? - Defense World

Oct 18, 2024
pulisher
Oct 15, 2024

CBD Life Sciences, Inc. (CBDL) Announces Strategic MOU With U.S. Armed Forces for Groundbreaking Mushroom Supplement - Quantisnow

Oct 15, 2024
pulisher
Oct 12, 2024

YCBD stock touches 52-week low at $0.44 amid market challenges By Investing.com - Investing.com South Africa

Oct 12, 2024

cbdMD Inc Stock (YCBD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$78.95
price up icon 0.92%
$11.11
price up icon 0.82%
$35.52
price up icon 0.57%
$119.11
price down icon 1.31%
$11.39
price up icon 1.24%
$128.57
price down icon 0.02%
Cap:     |  Volume (24h):